Fig. 7From: A multi-parametric prognostic model based on clinical features and serological markers predicts overall survival in non-small cell lung cancer patients with chronic hepatitis B viral infectionThe correlations between the prognostic model and TNM staging or clinical treatment in training cohort (a) and validation cohort (b)Back to article page